OBJECTIVE:
The aim of the PORTO-NeuroDevelopmental Assessment Study (PANDA) was to determine if children born after fetal growth restriction (FGR) pregnancies are at additional risk of early childhood development delays compared to children born small for gestational age (SGA). The objective of this secondary analysis was to describe the role of the cerebroplacental ratio (CPR) in the prediction of adverse early childhood neurodevelopmental outcome. STUDY DESIGN: Participants were prospectively recruited from the Perinatal Ireland multicenter observational PORTO study cohort. FGR was defined as birth weight <10 th with abnormal antenatal Doppler indices. SGA was similarly defined in the absence of abnormal Doppler indices. CPR was calculated using the pulsatility indices of the middle cerebral and divided by umbilical artery (UA) with an abnormal value <1. Children (n¼375) were assessed at three years using the Ages and Stages Questionnaire and the Bayley Scales of Infant and Toddler Development, III. SGA pregnancies with normal Doppler indices were compared with: 1) FGR cases with abnormal UA Doppler and normal CPR; or 2) FGR cases with both abnormal UA & CPR. Statistical analysis was performed using SAS version 9.2 via two-sample t-test with Bonferroni adjustment and pvalue of 0.00625 significant. RESULTS: Assessments were performed on 198 SGA children; 136 FGR children with abnormal UA Doppler and normal CPR and 41 FGR children with both abnormal UA Doppler and CPR. At three years of age, while there were no differences in head circumference, children who also had an abnormal CPR had persistently shorter stature (p¼0.005) and lower weight (p¼0.18). Children from FGR affected pregnancies demonstrated poorer neurodevelopmental outcome than their SGA counterparts. FGR pregnancies with an abnormal CPR had significantly poorer neurological outcome at three years of age across all measured variables (Tables 1 & 2) . CONCLUSION: We have demonstrated that growth restricted pregnancies with a CPR <1, have significantly increased risk of delayed neurodevelopment at three years of age when compared to pregnancies with abnormal UA Doppler alone. This study further substantiates the benefit of routine assessment of CPR in FGR pregnancies and for counseling parents regarding the long-term outcome of affected infants.
112 Urinary metabolomic profiles in pregnancy and association with fetal growth restriction STUDY DESIGN: Case-control study within ongoing prospective birth cohort. 30 cases of idiopathic FGR, defined as birth weight below the 5 th percentile for gestational age at delivery with no other pregnancy complications, were matched with 30 controls based on maternal age, race, body mass index, and gestational age at delivery. Non-targeted metabolomics analysis via gas chromatography/electron-ionization mass spectrometry was performed on urine samples from 10 and 26 weeks gestation on each participant. Deconvoluted spectra were annotated as metabolites, based on a spectral library. We examined stability in urinary metabolites across pregnancy using intraclass correlation coefficients (ICC) and calculated differences in urinary metabolite levels in cases and controls at each time point. Finally, we calculated differences in metabolites between the two time points and compared these changes in cases and controls. RESULTS: Birth weights of neonates in the control group were 3.2 kg (SD 0.5) on average compared to 2.2 kg (SD 0.3) among cases. We annotated 135 unique urinary metabolites. ICC for most metabolites was low (<0.4), indicating poor reliability across pregnancy; however, w35 metabolites showed moderate reliability (ICC 0.4-0.7). At both 10 and 26 weeks, urinary concentrations of malonic acid, found in citrus and food additives, and benzoic acid, found in berries and food additives, were significantly higher in cases of FGR compared to controls. Additional differences in raw concentrations as well as changes in levels over time were noted, although these findings were not robust to false discovery rate adjustment. CONCLUSION: This is the first study to investigate non-targeted urinary metabolite differences in cases of FGR compared to controls using mass spectrometry methods, which have higher resolution than other methods. A group of metabolites showed moderate reliability across gestation and may be more useful for the study of metabolomics in pregnancy. Specific urinary metabolites occurring in food sources differed in cases and controls at both visits in pregnancy and should be examined more carefully in larger studies.
